(e,e,e,e)-squalene

(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.

Cross Reference

Introduction

To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (e,e,e,e)-squalene?

(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene

MeSH term MeSH ID Detail
Leukemia P388 D007941 43 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Hairy Cell D007943 5 associated lipids
Lipodystrophy D008060 4 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Nervous System Diseases D009422 37 associated lipids
Neuroblastoma D009447 66 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Dermatitis, Occupational D009783 12 associated lipids
Occupational Diseases D009784 42 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Otitis Media D010033 12 associated lipids
Pain D010146 64 associated lipids
Parkinson Disease D010300 53 associated lipids
Parvoviridae Infections D010322 4 associated lipids
Periodontitis D010518 22 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Per page 10 20 50 100 | Total 84

PubChem Associated disorders and diseases

What pathways are associated with (e,e,e,e)-squalene

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (e,e,e,e)-squalene?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (e,e,e,e)-squalene?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (e,e,e,e)-squalene

Download all related citations
Per page 10 20 50 100 | Total 1766
Authors Title Published Journal PubMed Link
Huang ZR et al. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. 2009 Molecules pmid:19169201
Banzhoff A et al. MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. 2009 PLoS ONE pmid:19197383
Tritto E et al. Mechanism of action of licensed vaccine adjuvants. 2009 Vaccine pmid:19200813
Ansaldi F et al. Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. 2009 Vaccine pmid:19200846
Galli G et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19237568
Lambrecht BN et al. Mechanism of action of clinically approved adjuvants. 2009 Curr. Opin. Immunol. pmid:19246182
Morimoto Y et al. Total synthesis and determination of the absolute configuration of (+)-omaezakianol. 2009 Angew. Chem. Int. Ed. Engl. pmid:19248063
Burke B et al. Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits. 2009 Virology pmid:19249806
Baudner BC et al. MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). 2009 Pharm. Res. pmid:19255727
Radak BK et al. Modeling reactive scattering of F(2P) at a liquid squalane interface: a hybrid QM/MM molecular dynamics study. 2009 J Phys Chem A pmid:19323516
Liu Y et al. Influence of squalene feeding on plasma leptin, testosterone & blood pressure in rats. 2009 Indian J. Med. Res. pmid:19293441
Pass RF et al. Vaccine prevention of maternal cytomegalovirus infection. 2009 N. Engl. J. Med. pmid:19297572
Kato S et al. Biological safety of LipoFullerene composed of squalane and fullerene-C60 upon mutagenesis, photocytotoxicity, and permeability into the human skin tissue. 2009 Basic Clin. Pharmacol. Toxicol. pmid:19371265
Campagnac E et al. Fenpropimorph slows down the sterol pathway and the development of the arbuscular mycorrhizal fungus Glomus intraradices. 2009 Mycorrhiza pmid:19340463
Cheng J and Hoshino T Cyclization cascade of the C33-bisnorheptaprenoid catalyzed by recombinant squalene cyclase. 2009 Org. Biomol. Chem. pmid:19343258
Ryu A et al. Squalene as a target molecule in skin hyperpigmentation caused by singlet oxygen. 2009 Biol. Pharm. Bull. pmid:19721223
Clark TW et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. 2009 N. Engl. J. Med. pmid:19745215
Ghimire GP et al. Improved squalene production via modulation of the methylerythritol 4-phosphate pathway and heterologous expression of genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. 2009 Appl. Environ. Microbiol. pmid:19767465
Shabtay A et al. The potential of Pleurotus-treated olive mill solid waste as cattle feed. 2009 Bioresour. Technol. pmid:19683915
Pedroso N et al. Modulation of plasma membrane lipid profile and microdomains by H2O2 in Saccharomyces cerevisiae. 2009 Free Radic. Biol. Med. pmid:19027845
Laitinen K et al. Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety. 2009 Br. J. Nutr. pmid:19017423
Godio RP and Martín JF Modified oxidosqualene cyclases in the formation of bioactive secondary metabolites: biosynthesis of the antitumor clavaric acid. 2009 Fungal Genet. Biol. pmid:19130892
Wertz PW Human synthetic sebum formulation and stability under conditions of use and storage. 2009 Int J Cosmet Sci pmid:19134124
Matyas GR et al. Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. 2009 Biochim. Biophys. Acta pmid:19100711
Ghimire GP et al. Squalene-hopene cyclase (Spterp25) from Streptomyces peucetius: sequence analysis, expression and functional characterization. 2009 Biotechnol. Lett. pmid:19116691
Alam MM et al. Phase behavior, formation, and rheology of cubic phase and related gel emulsion in Tween 80/water/oil systems. 2009 J Oleo Sci pmid:19491531
Herchi W et al. Characterization and quantification of the aliphatic hydrocarbon fraction during linseed development ( Linum usitatissimum L.). 2009 J. Agric. Food Chem. pmid:19492811
Cho S et al. High-dose squalene ingestion increases type I procollagen and decreases ultraviolet-induced DNA damage in human skin in vivo but is associated with transient adverse effects. 2009 Clin. Exp. Dermatol. pmid:19522983
Petrick L and Dubowski Y Heterogeneous oxidation of squalene film by ozone under various indoor conditions. 2009 Indoor Air pmid:19500173
Rodas B and Bressani R [The oil, fatty acid and squalene content of varieties of raw and processed amaranth grain]. 2009 Arch Latinoam Nutr pmid:19480349
Mantzouridou F et al. Squalene versus ergosterol formation using Saccharomyces cerevisiae: combined effect of oxygen supply, inoculum size, and fermentation time on yield and selectivity of the bioprocess. 2009 J. Agric. Food Chem. pmid:19537785
Vesikari T et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. 2009 Pediatr. Infect. Dis. J. pmid:19561422
Bullon P et al. Gingival vascular damage in atherosclerotic rabbits: hydroxytyrosol and squalene benefits. 2009 Food Chem. Toxicol. pmid:19545596
Tokuhiro K et al. Overproduction of geranylgeraniol by metabolically engineered Saccharomyces cerevisiae. 2009 Appl. Environ. Microbiol. pmid:19592534
López P and Martín J Potential chemosignals associated with male identity in the amphisbaenian Blanus cinereus. 2009 Chem. Senses pmid:19406874
Al-Edresi S and Baie S Formulation and stability of whitening VCO-in-water nano-cream. 2009 Int J Pharm pmid:19429303
Camilloni B et al. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. 2009 Vaccine pmid:19410623
Galli G et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19416838
Phillips CJ et al. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. 2009 Vaccine pmid:19379786
Del Giudice G et al. Seasonal influenza vaccine provides priming for A/H1N1 immunization. 2009 Sci Transl Med pmid:20371459
Couvreur P ["Squalenoylation": a new approach to the design of anticancer and antiviral nanomedicines]. 2009 Bull. Acad. Natl. Med. pmid:19883017
Tong R et al. Stereo- and regioselective synthesis of squalene tetraepoxide. 2009 J. Org. Chem. pmid:19827774
Vesikari T et al. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. 2009 Vaccine pmid:19840662
Kim ES et al. Squalene-induced exogenous lipoid pneumonia in an infant. 2009 Pediatr Int pmid:19799746
Torrecilla Rojas MA et al. [Conventional influenza vaccination compared to MF59 adjuvanted subunit vaccine]. 2009 Aten Primaria pmid:19800151
Laursen AB [Dangerous adjuvant in swine influenza vaccine]. 2009 Ugeskr. Laeg. pmid:19866499
Reddy LH and Couvreur P Squalene: A natural triterpene for use in disease management and therapy. 2009 Adv. Drug Deliv. Rev. pmid:19804806
Gerpe A et al. 5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene. 2009 Bioorg. Med. Chem. pmid:19811923
Bildstein L et al. Freeze-drying of squalenoylated nucleoside analogue nanoparticles. 2009 Int J Pharm pmid:19782881
Leszczynska A et al. Investigating the effects of statins on cellular lipid metabolism using a yeast expression system. 2009 PLoS ONE pmid:20041128